« Back to Record
Citation APA

Cometta, A., Kern, W. V., De Bock, R., Paesmans, M., Vandenbergh, M., Crokaert, F., Engelhard, D., Marchetti, O., Akan, H., Skoutelis, A., Korten, V., Vandercam, M., Gaya, H., Padmos, A., Klastersky, J., Zinner, S. H., Glauser, M. P., Calandra, T., Viscoli, C., & International Antimicrobial Therapy Group of the European Organization for Research Treatment of Cancer, (2003). Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clinical infectious diseases, 37(3), 382-389. doi:10.1086/376637


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/124722

Cometta, A., Kern, W. V., De Bock, R., Paesmans, M., Vandenbergh, M., Crokaert, F., Engelhard, D., Marchetti, O., Akan, H., Skoutelis, A., Korten, V., Vandercam, M., Gaya, H., Padmos, A., Klastersky, J., Zinner, S. H., Glauser, M. P., Calandra, T., Viscoli, C., & International Antimicrobial Therapy Group of the European Organization for Research Treatment of Cancer, (2003). Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clinical infectious diseases, 37(3), 382-389. doi:10.1086/376637